MAR-AFATINIB

Identification of Mar-Afatinib

No description

Google image searchProduct monograph

Active ingredient

afatinib (afatinib dimaleate), 40 MG

DIN: 02517035

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: MARCAN PHARMACEUTICALS INC

Date: 31-JAN-2025

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EB — Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (ATC, ATC/DDD)
• L01EB03 — AFATINIB (ATC/DDD)

Reference brand drug: Giotrif

External Links for Mar-Afatinib

Search on Google

• Mar-Afatinib side effects
• Mar-Afatinib dosage
• afatinib side effects
• afatinib dosage

Marcan Pharmaceuticals Inc

Go to Marcan website to see drug product details. Sometimes you can find mar-afatinib photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.